Christopher Flowers was named head of the Division of Cancer Medicine at MD Anderson Cancer Center after a competitive national search.
The University of Texas MD Anderson Cancer Center launched its Institute for Cell Therapy Discovery & Innovation.
Christopher Flowers named head of the Division of Cancer Medicine at MD Anderson
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Jennifer Bickel has been named the inaugural vice president and chief wellness officer at the University of Texas MD Anderson Cancer Center. She will begin on Jan. 6, 2025.
The University of Texas MD Anderson Cancer Center hosted its ninth annual Boot Walk to End Cancer fundraising event on Nov. 2, in the Texas Medical Center. This year, the Boot Walk’s 7,000+ in-person participants and 1,200+ virtual participants from Houston and around the world joined together to raise $1.4 million to support the institution’s mission to end cancer.
The University of Texas MD Anderson Cancer Center announced an agreement to become a Women’s Cancer Partner with the Union for International Cancer Control, marking a significant collaboration to improve breast and cervical cancer care worldwide.
The University of Texas MD Anderson Cancer Center announced its first-ever academic journal, Advances in Cancer Education & Quality Improvement. The journal will publish research, training program summaries, and quality improvement interventions for the oncology provider community.
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.
